Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 26
Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office Appendix D 1994 National Vaccine Plan Goals, Objectives, and Anticipated Outcomes GOALS 1. Develop new and improved vaccines 2. Ensure the optimal safety and effectiveness of vaccines and immunizations 3. Better educate the public and members of the health professions on the benefits and risks of immunizations 4. Achieve better use of existing vaccines to prevent disease, disability, and death OBJECTIVES 1.1 Develop new and improved vaccines for priority diseases 2.1 Enhance the ability to evaluate the safety and effectiveness of vaccines 3.1 Increase public demand for immunization, especially among populations at risk of underimmunization 4.1 Ensure an adequate supply of vaccines 1.2 Ensure the Nation’s capability to detect and respond effectively to new and emerging diseases in the United States and abroad 2.2 Improve the surveillance and evaluation of adverse events following vaccination 3.2 Improve the immunization practices of all health care providers 4.2 Increase immunization coverage levels for infants and children 1.3 Enhance the process of translating technologic innovations into new vaccines 2.3 Ensure the optimal use of vaccines 3.3. Increase the awareness of the benefits of immunization among special target audiences (third-party payers, employers, legislators, community leaders, hospital administrators, etc.) 4.3 Maintain immunization coverage levels for school-aged children
OCR for page 27
Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office 1.4 Ensure the Nation’s capability to evaluate new vaccines, and to conduct prompt reviews of new and improved candidate vaccines 2.4 Continue to ensure fair and efficient compensation to individuals injured by vaccines 3.4 Develop more effective methods of communicating the benefits and risks of immunization to health care providers, patients, and parents/guardians 4.4 Increase immunization coverage levels among older adolescents, adults, and the elderly 1.5 Promote the improvement of existing vaccines and development of new vaccines ad vaccine-related technologies for other diseases of importance in developing countries 2.5 Promote and support the efforts of the World Health Organization to develop and harmonize international standards and improve regulatory capabilities in countries involved in vaccine production 3.5 Continue to evaluate the benefits and impact of immunization through the use of cost-effectiveness studies 4.5 Improve the surveillance of vaccine preventable diseases to assess the impact of immunization programs 4.6 Establish registry and immunization tracking systems 4.7 Enhance immunization coverage to strengthen national defense 4.8 Enhance immunization coverage of international travelers who are of highest risk of acquiring vaccine-preventable diseases 4.9 Eradicate poliomyelitis globally 4.10 Promote better control of neonatal tetanus and measles, worldwide 4.11 Promote the self-sustaining capacity of immunization programs in developing countries ANTICIPATED15 OUTCOMES Provision of adequate resources to make possible the vigorous and comprehensive pursuit of the wide range of activities outlined in the National Vaccine Plan could result in substantial health benefits for the American people by the year 2000. These benefits are expected to be realized as the following outcomes: 15 Also described as “predicted” outcomes in the National Vaccine Plan
OCR for page 28
Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office Age-appropriate immunization with all recommended vaccines will be extended to at least 90 percent of infants and children, and access to affordable vaccination services will be made available for every person in the United States. Diphtheria, tetanus, poliomyelitis, measles, rubella, mumps, some forms of hepatitis, pertussis (whooping cough), and bacterial meningitis (from Haemophilus influenzae type b) will be essentially eliminated as significant causes of death, disease, and disability in the United States. Educational communication networks will be in place that will inform all health care providers, communities, and families of the benefits and risks of vaccination. In a global context, polio will be drastically reduced, if not eliminated, and neonatal tetanus and measles will be better controlled. Pneumococcal pneumonia and influenza in American adults over the age of 65 will be significantly reduced. A nationwide system will monitor the vaccines that children receive, and will remind parents when individual infants and children should be vaccinated. A nationwide surveillance system will report and investigate cases of vaccine-preventable diseases. Vaccine safety and efficacy will be continuously monitored, and adverse events following immunization will be reported and carefully analyzed. Improved vaccines will replace some of the vaccines in current use. Some vaccines requiring multiple doses and multiple contacts with the health care system will be replaced by more cost-effective ones that will improve people’s access to immunization. Many new vaccines will be developed, or be much closer to licensure, for diseases for which effective vaccines do not now exist. New mechanisms for the more rapid assessment of vaccines proposed for licensure will be in place. A reliable supply of all recommended vaccines and a capability to respond to emergencies and emergent threats to public health will be achieved and sustained. Information on the cost and benefits of the National Vaccine Plan will be made available on an ongoing basis to the American people.